Hope for RA patients Who've run out of options: experimental drug enters human testing
NCT ID NCT07412704
Summary
This early-stage trial is testing a new drug called BMS-986528 in adults with rheumatoid arthritis that hasn't responded well to other treatments. The study will check if the drug is safe and how it affects the body, while also looking for early signs that it might help control arthritis symptoms. Researchers will enroll 84 participants to gather initial data on how the drug works in people with this difficult-to-treat condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHRITIS, RHEUMATOID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Local Institution - 0001
Shanghai, Shanghai Municipality, 200127, China
Contact
-
Local Institution - 0006
Beijing, Beijing Municipality, 100091, China
Contact
-
Local Institution - 0007
Nanchang, Jiangxi, 330006, China
Contact
-
Local Institution - 0010
Zhengzhou, Henan, 450000, China
Contact
-
Local Institution - 0017
Roma, 00168, Italy
Contact
-
Local Institution - 0019
Rozzano, Milano, 20089, Italy
Contact
-
Local Institution - 0020
Shanghai, Shanghai Municipality, 200040, China
Contact
-
Local Institution - 0021
Cologne, 50937, Germany
Contact
-
Local Institution - 0022
Berlin, 10117, Germany
Contact
-
Local Institution - 0023
Józefów, Masovian Voivodeship, 05-410, Poland
Contact
-
Local Institution - 0027
Geneva, 1211, Switzerland
Contact
-
Local Institution - 0028
Herne, 44652, Germany
Contact
-
Local Institution - 0037
Bern, 3010, Switzerland
Contact
-
Local Institution - 0039
A Coruña, A Coruña [La Coruña], 15006, Spain
Contact
-
Local Institution - 0040
München, Bavaria, 81377, Germany
Contact
-
Local Institution - 0045
Budapest, 1085, Hungary
Contact
-
Local Institution - 0048
Merksem, Flanders, 2170, Belgium
Contact
-
Local Institution - 0049
Leuven, 3000, Belgium
Contact
-
Local Institution - 0050
Aurora, Colorado, 80045, United States
Contact
-
Local Institution - 0051
DeSoto, Texas, 75115, United States
-
Local Institution - 0055
South Miami, Florida, 33143, United States
Contact
-
Local Institution - 0056
Sendenhorst, North Rhine-Westphalia, 48324, Germany
Contact
-
Local Institution - 0057
San Antonio, Texas, 78229, United States
Contact
-
Local Institution - 0058
Córdoba, Córdoba, 14004, Spain
Contact
-
Local Institution - 0060
Ivano-Frankivsk, Ivano-Frankivsk Oblast, 76008, Ukraine
Contact
-
Local Institution - 0061
Ternopil, 46002, Ukraine
Contact
-
Local Institution - 0062
Kyiv, 02000, Ukraine
Contact
-
Local Institution - 0063
Poltava, Poltava Oblast, 36011, Ukraine
Contact
-
Local Institution - 0064
Kyiv, Kyiv Oblast, 01135, Ukraine
Contact
-
Local Institution - 0065
Potsdam, 14467, Germany
Contact
-
Local Institution - 0066
Portland, Oregon, 97239, United States
Contact
Conditions
Explore the condition pages connected to this study.